ArticleJournal of clinical microbiology2001
Basidiobolus ranarum as an etiologic agent of gastrointestinal zygomycosis.
Article in Journal of clinical microbiology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 112 citations in OpenAlex.
- Gastrointestinal Basidiobolomycosis with Biliary Tract Involvement in the Early Postpartum Period: A Case Report and Literature Review.Infectious disease reports · 2026Article
- When Eosinophils Mislead: Gastrointestinal Basidiobolomycosis Initially Misdiagnosed as Eosinophilic Colitis.European journal of case reports in internal medicine · 2026Article
- Unveiling basidiobolomycosis: key imaging features and clinical correlations.BMC infectious diseases · 2025Article
- Atypical presentation for a gastrointestinal basidiobolomycosis and rare side effect of Voriconazole: A case report and literature review.Medical mycology case reports · 2025Article
- Navigating treatment for basidiobolomycosis: a qualitative review of 24 cases.BMC infectious diseases · 2024Article
- Gastrointestinal basidiobolomycosis masquerading as cancer.Radiology case reports · 2024Article
- Gastrointestinal Basidiobolomycosis: A Case Series.Cureus · 2024Article
- Disseminated Gastrointestinal Basidiobolomycosis: A Case Report with Review of Diagnostic Clues.Case reports in medicine · 2024Article
- Case report: Localized coloproctitis caused by novelFrontiers in veterinary science · 2024Article
- Divergent Evolution of Early Terrestrial Fungi Reveals the Evolution of Mucormycosis Pathogenicity Factors.Genome biology and evolution · 2023Article
- Article
- Zoonotic diseases of fish and their prevention and control.The veterinary quarterly · 2022Review
- Subcutaneous entomophthoromycosis in an immunocompetent individual: a localised forearm swelling.BMJ case reports · 2022Article
- Pediatric intussusception due to basidiobolomycosis: a case report and literature review.BMC pediatrics · 2022Review
- Visceral Basidiobolomycosis Causing Bowel Ischemia.Cureus · 2022Article
- An old confusion: Entomophthoromycosis versus mucormycosis and their main differences.Frontiers in microbiology · 2022Review
- Article
- Primary Basidiobolomycosis of the Cecum in Immunocompetent Patients: Two Case Reports.Gastroenterology research · 2021Article
- Colorectal basidiobolomycosis in a dog.Journal of veterinary internal medicine · 2020Article
- Invasive Basidiobolomycosis Presenting as Retroperitoneal Fibrosis: A Case Report.International journal of environmental research and public health · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Basidiobolus ranarum is a known cause of subcutaneous zygomycosis. Recently, its etiologic role in gastrointestinal infections has been increasingly recognized. While the clinical presentation of the subcutaneous disease is quite characteristic and the disease is easy to diagnose, gastrointestinal basidiobolomycosis poses diagnostic difficulties; its clinical presentation is nonspecific, there are no identifiable risk factors, and all age groups are susceptible. The case of gastrointestinal basidiobolomycosis described in the present report occurred in a 41-year-old Indian male who had a history of repair of a left inguinal hernia 2 years earlier and who is native to the southern part of India, where the subcutaneous form of the disease is indigenous. Diagnosis is based on the isolation of B. ranarum from cultures of urine and demonstration of broad, sparsely septate hyphal elements in histopathologic sections of the colon, with characteristic eosinophilic infiltration and the Splendore-Hoeppli phenomenon. The titers of both immunoglobulin G (IgG) and IgM antibodies to locally produced antigen of the fungus were elevated. The patient failed to respond to 8 weeks of amphotericin B therapy, and the isolate was later found to be resistant to amphotericin B, itraconazole, fluconazole, and flucytosine but susceptible to ketoconazole and miconazole. One other noteworthy feature of the fungus was that the patient's serum showed raised levels of Th2-type cytokines (interleukins 4 and 10) and tumor necrosis factor alpha. The present report underscores the need to consider gastrointestinal basidiobolomycosis in the differential diagnosis of inflammatory bowel diseases and suggests that, perhaps, more time should be invested in developing standardized serologic reagents that can be used as part of a less invasive means of diagnosis of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.